{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:05:41Z","timestamp":1790654741793,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T00:00:00Z","timestamp":1543968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771450"],"award-info":[{"award-number":["81771450"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471358"],"award-info":[{"award-number":["81471358"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Science and Technology Commission Foundation","award":["14411969000"],"award-info":[{"award-number":["14411969000"]}]},{"name":"Shanghai Municipal Education Commission\u2014Gaofeng Clinical Medicine Grant Support","award":["20152530"],"award-info":[{"award-number":["20152530"]}]},{"DOI":"10.13039\/501100010032","name":"Shanghai Municipal Commission of Health and Family Planning Foundation","doi-asserted-by":"crossref","award":["201540029"],"award-info":[{"award-number":["201540029"]}],"id":[{"id":"10.13039\/501100010032","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Municipal Commission of Health and Family Planning, Key Developing Disciplines","award":["2015ZB0405"],"award-info":[{"award-number":["2015ZB0405"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00213-018-5136-9","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T23:57:20Z","timestamp":1543967840000},"page":"1273-1279","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial"],"prefix":"10.1007","volume":"236","author":[{"given":"Feikang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisheng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4071-1627","authenticated-orcid":false,"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,5]]},"reference":[{"key":"5136_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jnutbio.2018.02.012","volume":"58","author":"K Albracht-Schulte","year":"2018","unstructured":"Albracht-Schulte K, Kalupahana NS, Ramalingam L, Wang S, Rahman SM, Robert-McComb J, Moustaid-Moussa N (2018) Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update. J Nutr Biochem 58:1\u201316","journal-title":"J Nutr Biochem"},{"key":"5136_CR2","doi-asserted-by":"publisher","first-page":"390","DOI":"10.4239\/wjd.v8.i8.390","volume":"8","author":"A Annamalai","year":"2017","unstructured":"Annamalai A, Kosir U, Tek C (2017) Prevalence of obesity and diabetes in patients with schizophrenia. World J Diabetes 8:390\u2013396","journal-title":"World J Diabetes"},{"key":"5136_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.atherosclerosis.2008.03.001","volume":"201","author":"YQ Bao","year":"2008","unstructured":"Bao YQ, Lu JX, Wang C, Yang M, Li HT, Zhang XY, Zhu JH, Lu HJ, Jia WP, Xiang KS (2008) Optimal waist circumference cutoffs for abdominal obesity in Chinese. Atherosclerosis 201:378\u2013384","journal-title":"Atherosclerosis"},{"key":"5136_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.psychres.2017.12.028","volume":"261","author":"F Behdani","year":"2018","unstructured":"Behdani F, Roudbaraki SN, Saberi-Karimian M, Tayefi M, Hebrani P, Akhavanrezayat A, Amlashi SV, Ferns GA, Ghayour-Mobarhan M (2018) Assessment of the efficacy of omega-3 fatty acids on metabolic and inflammatory parameters in patients with schizophrenia taking clozapine and sodium valproate. Psychiatry Res 261:243\u2013247","journal-title":"Psychiatry Res"},{"key":"5136_CR5","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.psyneuen.2012.04.001","volume":"37","author":"W Beumer","year":"2012","unstructured":"Beumer W, Drexhage RC, De Wit H, Versnel MA, Drexhage HA, Cohen D (2012) Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome. Psychoneuroendocrinology 37:1901\u20131911","journal-title":"Psychoneuroendocrinology"},{"key":"5136_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/JCP.0b013e318166c4f7","volume":"28","author":"AB Birkenaes","year":"2008","unstructured":"Birkenaes AB, Birkeland KI, Engh JA, Faerden A, Jonsdottir H, Ringen PA, Friis S, Opjordsmoen S, Andreassen OA (2008) Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions. J Clin Psychopharmacol 28:132\u2013137","journal-title":"J Clin Psychopharmacol"},{"key":"5136_CR7","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/S0006-3223(01)01256-2","volume":"50","author":"PF Buckley","year":"2001","unstructured":"Buckley PF (2001) Broad therapeutic uses of atypical antipsychotic medications. Biol Psychiatry 50:912\u2013924","journal-title":"Biol Psychiatry"},{"key":"5136_CR8","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1042\/BST20160474","volume":"45","author":"PC Calder","year":"2017","unstructured":"Calder PC (2017) Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans 45:1105\u20131115","journal-title":"Biochem Soc Trans"},{"key":"5136_CR9","doi-asserted-by":"crossref","unstructured":"Chesney E, Goodwin GM, Fazel S (2014) Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry 13:153\u2013160","DOI":"10.1002\/wps.20128"},{"key":"5136_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3109\/10641960903254448","volume":"32","author":"AF Cicero","year":"2010","unstructured":"Cicero AF, Derosa G, Di Gregori V, Bove M, Gaddi AV, Borghi C (2010) Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study. Clin Exp Hypertens 32:137\u2013144","journal-title":"Clin Exp Hypertens"},{"key":"5136_CR11","doi-asserted-by":"crossref","unstructured":"de Witte L, Tomasik J, Schwarz E, Guest PC, Rahmoune H, Kahn RS, Bahn S (2014) Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophr Res 154:23\u201329","DOI":"10.1016\/j.schres.2014.02.005"},{"key":"5136_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11883-010-0098-3","volume":"12","author":"S Devaraj","year":"2010","unstructured":"Devaraj S, Valleggi S, Siegel D, Jialal I (2010) Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome. Curr Atheroscler Rep 12:110\u2013118","journal-title":"Curr Atheroscler Rep"},{"key":"5136_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.pcad.2018.03.006","volume":"61","author":"A Elagizi","year":"2018","unstructured":"Elagizi A, Lavie CJ, Marshall K, DiNicolantonio JJ, O\u2019Keefe JH, Milani RV (2018) Omega-3 polyunsaturated fatty acids and cardiovascular health: a comprehensive review. Prog Cardiovasc Dis 61:76\u201385","journal-title":"Prog Cardiovasc Dis"},{"key":"5136_CR14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1056\/NEJM198902023200501","volume":"320","author":"S Endres","year":"1989","unstructured":"Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Cannon JG, Rogers TS, Klempner MS, Weber PC et al (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320:265\u2013271","journal-title":"N Engl J Med"},{"key":"5136_CR15","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448\u2013454","journal-title":"N Engl J Med"},{"key":"5136_CR16","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F (2005) Diagnosis and management of the metabolic syndrome\u2014an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement. Circulation 112:2735\u20132752","journal-title":"Circulation"},{"key":"5136_CR17","doi-asserted-by":"crossref","unstructured":"Gurusamy J, Gandhi S, Damodharan D, Ganesan V, Palaniappan M (2018) Exercise, diet and educational interventions for metabolic syndrome in persons with schizophrenia: A systematic review. Asian J Psychiatr 36:73\u201385","DOI":"10.1016\/j.ajp.2018.06.018"},{"key":"5136_CR18","doi-asserted-by":"crossref","unstructured":"Huang M, Yu L, Pan F, Lu S, Hu S, Hu J, Chen J, Jin P, Qi H, Xu Y (2018) A randomized, 13-week study assessing the efficacy and metabolic effects of paliperidone palmitate injection and olanzapine in first episode schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry 81:122\u2013130","DOI":"10.1016\/j.pnpbp.2017.10.021"},{"key":"5136_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41398-018-0116-8","volume":"8","author":"AC Kao","year":"2018","unstructured":"Kao AC, Spitzer S, Anthony DC, Lennox B, Burnet PWJ (2018) Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota. Transl Psychiatry 8:66","journal-title":"Transl Psychiatry"},{"key":"5136_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261\u2013276","journal-title":"Schizophr Bull"},{"key":"5136_CR21","doi-asserted-by":"crossref","unstructured":"Kim YS, Xun P, He K (2015) Fish consumption, long-chain omega-3 polyunsaturated fatty acid intake and risk of metabolic syndrome: a meta-analysis. Nutrients 7:2085\u20132100","DOI":"10.3390\/nu7042085"},{"key":"5136_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1365-2265.2004.02088.x","volume":"61","author":"J Kvetny","year":"2004","unstructured":"Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J (2004) Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol 61:232\u2013238","journal-title":"Clin Endocrinol"},{"key":"5136_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.bbi.2018.06.004","volume":"73","author":"VF Labrousse","year":"2018","unstructured":"Labrousse VF, Leyrolle Q, Amadieu C, Aubert A, Sere A, Coutureau E, Gregoire S, Bretillon L, Pallet V, Gressens P, Joffre C, Nadjar A, Laye S (2018) Dietary omega-3 deficiency exacerbates inflammation and reveals spatial memory deficits in mice exposed to lipopolysaccharide during gestation. Brain Behav Immun 73:427\u2013440","journal-title":"Brain Behav Immun"},{"key":"5136_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.psyneuen.2012.05.005","volume":"38","author":"Z Li","year":"2013","unstructured":"Li Z, Qi D, Chen J, Zhang C, Yi Z, Yuan C, Wang Z, Hong W, Yu S, Cui D, Fang Y (2013) Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-alpha) in the Chinese patients with major depressive disorder: a prospective longitudinal study. Psychoneuroendocrinology 38:107\u2013114","journal-title":"Psychoneuroendocrinology"},{"key":"5136_CR25","doi-asserted-by":"crossref","unstructured":"Lorente-Cebri\u00e1n S, Costa AG, Navas-Carretero S, Zabala M, Mart\u00ednez JA, Moreno-Aliaga MJ (2013) Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence. J Physiol Biochem 69:633\u2013651","DOI":"10.1007\/s13105-013-0265-4"},{"key":"5136_CR26","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1210\/endo.132.5.8477669","volume":"132","author":"RA Memon","year":"1993","unstructured":"Memon RA, Grunfeld C, Moser AH, Feingold KR (1993) Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology 132:2246\u20132253","journal-title":"Endocrinology"},{"key":"5136_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.4088\/JCP.v63n0509","volume":"63","author":"JM Meyer","year":"2002","unstructured":"Meyer JM (2002) A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year. J Clin Psychiatry 63:425\u2013433","journal-title":"J Clin Psychiatry"},{"key":"5136_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12884-018-1899-6","volume":"18","author":"EL Mozurkewich","year":"2018","unstructured":"Mozurkewich EL, Berman DR, Vahratian A, Clinton CM, Romero VC, Chilimigras JL, Vazquez D, Qualls C, Djuric Z (2018) Effect of prenatal EPA and DHA on maternal and umbilical cord blood cytokines. BMC Pregnancy Childbirth 18:261","journal-title":"BMC Pregnancy Childbirth"},{"key":"5136_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12933-018-0740-x","volume":"17","author":"LL O\u2019Mahoney","year":"2018","unstructured":"O\u2019Mahoney LL, Matu J, Price OJ, Birch KM, Ajjan RA, Farrar D, Tapp R, West DJ, Deighton K, Campbell MD (2018) Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials. Cardiovasc Diabetol 17:98","journal-title":"Cardiovasc Diabetol"},{"key":"5136_CR30","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","volume":"142","author":"DY Oh","year":"2010","unstructured":"Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan WQ, Li PP, Lu WJ, Watkins SM, Olefsky JM (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142:687\u2013698","journal-title":"Cell"},{"key":"5136_CR31","doi-asserted-by":"crossref","unstructured":"Penninx BWJH, Lange SMM (2018) Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications. Dialogues Clin Neurosci 20:63\u201373","DOI":"10.31887\/DCNS.2018.20.1\/bpenninx"},{"key":"5136_CR32","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1194\/jlr.R600021-JLR200","volume":"48","author":"C Popa","year":"2007","unstructured":"Popa C, Netea MG, van Riel PL, van der Meer JW, Stalenhoef AF (2007) The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res 48:751\u2013762","journal-title":"J Lipid Res"},{"key":"5136_CR33","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/MED.0b013e32833de61c","volume":"17","author":"P Pramyothin","year":"2010","unstructured":"Pramyothin P, Khaodhiar L (2010) Metabolic syndrome with the atypical antipsychotics. Curr Opin Endocrinol Diabetes Obes 17:460\u2013466","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"5136_CR34","doi-asserted-by":"crossref","unstructured":"Rahmani E, Jamilian M, Dadpour B, Nezami Z, Vahedpoor Z, Mahmoodi S, Aghadavod E, Taghizadeh M, Beiki Hassan A, Asemi Z (2018) The effects of fish oil on gene expression in patients with polycystic ovary syndrome. Eur J Clin Investig 48:e12893","DOI":"10.1111\/eci.12893"},{"key":"5136_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plefa.2017.10.006","volume":"128","author":"GC Shearer","year":"2018","unstructured":"Shearer GC, Borkowski K, Puumala SL, Harris WS, Pedersen TL, Newman JW (2018) Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids. Prostaglandins Leukot Essent Fat Acids 128:1\u201310","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"5136_CR36","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1200\/JCO.1988.6.2.344","volume":"6","author":"ML Sherman","year":"1988","unstructured":"Sherman ML, Spriggs DR, Arthur KA, Imamura K, Frei E 3rd, Kufe DW (1988) Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism. J Clin Oncol 6:344\u2013350","journal-title":"J Clin Oncol"},{"key":"5136_CR37","doi-asserted-by":"crossref","unstructured":"Stapel B, Sieve I, Falk CS, Bleich S, Hilfiker-Kleiner D, Kahl KG (2018) Second generation atypical antipsychotics olanzapine and aripiprazole reduce expression and secretion of inflammatory cytokines in human immune cells. J Psychiatr Res 105:95\u2013102","DOI":"10.1016\/j.jpsychires.2018.08.017"},{"key":"5136_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/oxfordjournals.schbul.a006986","volume":"29","author":"TS Stroup","year":"2003","unstructured":"Stroup TS, McEvoy JP, Swartz MS, Byerly MJ, Glick ID, Canive JM, McGee MF, Simpson GM, Stevens MC, Lieberman JA (2003) The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull 29:15\u201331","journal-title":"Schizophr Bull"},{"key":"5136_CR39","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/wps.20252","volume":"14","author":"D Vancampfort","year":"2015","unstructured":"Vancampfort D, Stubbs B, Mitchell AJ, De Hert M, Wampers M, Ward PB, Rosenbaum S, Correll CU (2015) Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry 14:339\u2013347","journal-title":"World Psychiatry"},{"key":"5136_CR40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2147\/vhrm.2006.2.3.251","volume":"2","author":"C Schacky von","year":"2006","unstructured":"von Schacky C (2006) A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels. Vasc Health Risk Manag 2:251\u2013262","journal-title":"Vasc Health Risk Manag"},{"key":"5136_CR41","doi-asserted-by":"crossref","unstructured":"Wang P, Cai J, Ni J, Zhang J, Tang W, Zhang C (2016) The NCAN gene: schizophrenia susceptibility and cognitive dysfunction. Neuropsychiatr Dis Treat 12:2875\u20132883","DOI":"10.2147\/NDT.S118160"},{"key":"5136_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072652","volume":"8","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Chen M, Wu Z, Chen J, Yu S, Fang Y, Zhang C (2013) Association study of Val66Met polymorphism in brain-derived neurotrophic factor gene with clozapine-induced metabolic syndrome: preliminary results. PLoS One 8:e72652","journal-title":"PLoS One"},{"key":"5136_CR43","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1007\/s00213-013-3410-4","volume":"231","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Chen M, Chen J, Wu Z, Yu S, Fang Y, Zhang C (2014) Metabolic syndrome in patients taking clozapine: prevalence and influence of catechol-O-methyltransferase genotype. Psychopharmacology 231:2211\u20132218","journal-title":"Psychopharmacology"},{"key":"5136_CR44","doi-asserted-by":"publisher","first-page":"e1460","DOI":"10.4088\/JCP.15m10047","volume":"77","author":"C Zhang","year":"2016","unstructured":"Zhang C, Chen MJ, Wu GJ, Wang ZW, Rao SZ, Zhang Y, Yi ZH, Yang WM, Gao KM, Song LS (2016) Effectiveness of antipsychotic drugs for 24-month maintenance treatment in first-episode schizophrenia: evidence from a community-based \u201creal-world\u201d study. J Clin Psychiatry 77:e1460\u2013e1466","journal-title":"J Clin Psychiatry"},{"key":"5136_CR45","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.psyneuen.2017.04.014","volume":"81","author":"C Zhang","year":"2017","unstructured":"Zhang C, Fang X, Yao P, Mao Y, Cai J, Zhang Y, Chen M, Fan W, Tang W, Song L (2017a) Metabolic adverse effects of olanzapine on cognitive dysfunction: a possible relationship between BDNF and TNF-alpha. Psychoneuroendocrinology 81:138\u2013143","journal-title":"Psychoneuroendocrinology"},{"key":"5136_CR46","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/tpj.2015.68","volume":"17","author":"C Zhang","year":"2017","unstructured":"Zhang C, Zhang Y, Cai J, Chen M, Song L (2017b) Complement 3 and metabolic syndrome induced by clozapine: a cross-sectional study and retrospective cohort analysis. Pharmacogenomics J 17:92\u201397","journal-title":"Pharmacogenomics J"},{"key":"5136_CR47","doi-asserted-by":"crossref","unstructured":"Zhang C, Lv Q, Fan W, Tang W, Yi Z (2017c) Influence of CFH gene on symptom severity of schizophrenia. Neuropsychiatr Dis Treat 13:697\u2013706","DOI":"10.2147\/NDT.S132108"},{"key":"5136_CR48","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00213-018-4835-6","volume":"235","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Fang XY, Fan WX, Tang W, Cai J, Song LS, Zhang C (2018) Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study. Psychopharmacology 235:1191\u20131198","journal-title":"Psychopharmacology"},{"key":"5136_CR49","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.diabres.2010.09.001","volume":"90","author":"H Zhou","year":"2010","unstructured":"Zhou H, Guo ZR, Yu LG, Hu XS, Xu BH, Liu HB, Wu M, Zhou ZY (2010) Evidence on the applicability of the ATPIII, IDF and CDS metabolic syndrome diagnostic criteria to identify CVD and T2DM in the Chinese population from a 6.3-year cohort study in mid-eastern China. Diabetes Res Clin Pract 90:319\u2013325","journal-title":"Diabetes Res Clin Pract"},{"key":"5136_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/jhg.2014.94","volume":"60","author":"Y Zhu","year":"2014","unstructured":"Zhu Y, Wang Z, Ni J, Zhang Y, Chen M, Cai J, Li X, Zhang W, Zhang C (2014) Genetic variant in NDUFS1 gene is associated with schizophrenia and negative symptoms in Han Chinese. J Hum Genet 60:11\u201316","journal-title":"J Hum Genet"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-5136-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-018-5136-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-5136-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T15:34:34Z","timestamp":1605540874000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-018-5136-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,5]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["5136"],"URL":"https:\/\/doi.org\/10.1007\/s00213-018-5136-9","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,5]]},"assertion":[{"value":"13 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures for this study were reviewed and approved by the Institutional Review Boards of the Shanghai Mental Health Center and other participating institutions. This study was performed in strict accordance with the Declaration of Helsinki and other relevant national and international regulations.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}